Trial of Roflumilast in Asthma Management (TRIM)
This reseach is being done to evaluate the effectiveness of using Roflumilast as an alternative treatement of poorly controlled Asthma in obese patients.
Study phase: II
Basic eligibility criteria:
Please contact the study coordinator for additional eligibility information.
- Subjects must be at least 18 years olf
- Subjects must have been diagnosed with Asthma
-Subject who struggle to maintain a health BMI
- Subjects that don't have other medical conditions that would hinder their participation in a drug study.
TRIM is a 24 week study.
The subject will need to attend 7 clinic vivist that will take about 2-3 hours each.
Subjects will need to maintain Asthma Diaries at home.
Primary disease category: Asthma & Lung
This study is enrolling healthy volunteers.
Sponsor: Johns Hopkins University/ American Lung Association/ National Heart, Lung, and Blood Institute (NHLBI)
Protocol number: TRIM (UA# 1803342605)
Projected enrollment dates: September 2019 to April 2020
Official study title: Trial of Roflumilast in Asthma Management (TRIM)